Key clinical point: Differences in the gut microbiome may affect the risk of relapse in pediatric-onset MS.
Major finding: Blautia stercoris had the most significant association with relapse risk (HR, 2.50).
Study details: An examination of stool samples from 53 patients with pediatric-onset MS.
Disclosures: The National MS Society and the National Institute of Neurological Disorders and Stroke funded the study. Ms. Horton had no disclosures.
Horton M et al. MSVirtual2020, Abstract LB01.05.